Advertisement
In conjunction with the issuance of the press release, Idenix managementwill host a conference call at 8:30 a.m. ET on Tuesday, July 29, 2008 todiscuss the company's financial results for the second quarter of 2008 andprovide an update on the company's discovery and development programs.
Advertisement
To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475International and enter passcode 56201724 or to listen to a live audio webcastof the call, go to "Calendar of Events" in the Idenix Investor Center athttp://www.idenix.com. A replay of the call will also be available from 11:30a.m. ET on July 29, 2008 until 11:59 p.m. ET on August 12, 2008. To access thereplay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International andenter passcode 56201724. An archived webcast will also be available for twoweeks after the call on the Idenix website.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,is a biopharmaceutical company engaged in the discovery and development ofdrugs for the treatment of human viral and other infectious diseases. Idenix'scurrent focus is on the treatment of infections caused by the hepatitis Cvirus and HIV. For further information about Idenix, please refer tohttp://www.idenix.com.
Idenix Pharmaceutical Contact:
Amy Sullivan (617) 995-9901
SOURCE Idenix Pharmaceuticals, Inc.
